- Home
- DSGN vs HYMC Comparison
DSGN vs HYMC Comparison
Compare DSGN & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- HYMC
- Stock Information
- Founded
- DSGN 2017
- HYMC N/A
- Country
- DSGN United States
- HYMC United States
- Employees
- DSGN N/A
- HYMC N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- HYMC Precious Metals
- Sector
- DSGN Health Care
- HYMC Basic Materials
- Exchange
- DSGN Nasdaq
- HYMC Nasdaq
- Market Cap
- DSGN 208.9M
- HYMC 250.2M
- IPO Year
- DSGN 2021
- HYMC N/A
- Fundamental
- Price
- DSGN $6.54
- HYMC $6.47
- Analyst Decision
- DSGN
- HYMC
- Analyst Count
- DSGN 0
- HYMC 0
- Target Price
- DSGN N/A
- HYMC N/A
- AVG Volume (30 Days)
- DSGN 173.8K
- HYMC 1.1M
- Earning Date
- DSGN 11-06-2025
- HYMC 11-04-2025
- Dividend Yield
- DSGN N/A
- HYMC N/A
- EPS Growth
- DSGN N/A
- HYMC N/A
- EPS
- DSGN N/A
- HYMC N/A
- Revenue
- DSGN N/A
- HYMC N/A
- Revenue This Year
- DSGN N/A
- HYMC N/A
- Revenue Next Year
- DSGN N/A
- HYMC N/A
- P/E Ratio
- DSGN N/A
- HYMC N/A
- Revenue Growth
- DSGN N/A
- HYMC N/A
- 52 Week Low
- DSGN $2.60
- HYMC $1.99
- 52 Week High
- DSGN $7.77
- HYMC $7.18
- Technical
- Relative Strength Index (RSI)
- DSGN 54.51
- HYMC 63.12
- Support Level
- DSGN $5.88
- HYMC $5.93
- Resistance Level
- DSGN $7.59
- HYMC $6.85
- Average True Range (ATR)
- DSGN 0.51
- HYMC 0.49
- MACD
- DSGN -0.06
- HYMC -0.06
- Stochastic Oscillator
- DSGN 37.42
- HYMC 54.05
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About HYMC Hycroft Mining Holding Corporation
Hycroft Mining Holding Corp is a gold and silver producer. Its operating mine, the Hycroft Mine, is an open-pit heap leach operation located approximately fifty four miles west of Winnemucca, Nevada.